No Data
No Data
No Data
Samsara Vision Announces First U.S. Surgeries of the SING IMT™ (Smaller-Incision New-Generation Implantable Miniature Telescope), for Age-Related Macular Degeneration as part of the CONCERTO Study
FAR HILLS, N.J.--(BUSINESS WIRE)--#AMD--Samsara Vision, a company focused on bringing vision and freedom back to patients with late-stage, age-related macular degeneration (AMD) through advanced visua
Samsara Vision to Initiate a U.S. PMA Supplemental Study of the SING IMT™, a New-Generation Technology for Age-Related Macular Degeneration
FAR HILLS, N.J.--(BUSINESS WIRE)--#AMD--Samsara Vision, a company focused on bringing vision and freedom back to patients with late-stage, age-related macular degeneration (AMD) through advanced visua
BRIEF-Samsara Vision To Initiate A U.S. Pma Supplemental Study Of The Sing Imt™, A New-Generation Technology For Age-Related Macular Degeneration
April 20 (Reuters) - Samsara Vision Inc SMSA.O :* SAMSARA VISION TO INITIATE A U.S. PMA SUPPLEMENTAL STUDY OF THE SING IMT™, A NEW-GENERATION TECHNOLOGY FOR AGE-RELATED MACULAR DEGENERATION* SAMSARA
Samsara Vision downsizes proposed IPO by 40% to $15M
Ophthalmic device maker Samsara Vision (NASDAQ:SMSA) has downsized its proposed initial public offering by 40% to $15M. According to a filing, Samsara Vision now plans to offer 2.5M shares priced bet
Samsara Vision Cuts Size of Planned IPO
By Colin Kellaher Samsara Vision Inc. on Friday cut the size of its planned initial public offering to 2.5 million shares from about 4.17 million. The Far Hills, N.J., medical-device compa
Samsara Vision reportedly delays IPO, had filed to raise up to $29.4M
Samsara Vision (NASDAQ:SMSA) has reportedly delayed its initial public offering, which had been expected Friday. According to a Renaissance Capital report, Samsara Vision shares were slated to begin
No Data